Latest filing published 28 Sept 2010 for Myriad Pharmaceuticals, Inc..
Insider track record
No signal scores available.
Andrew Gibbs: trading record in brief
Andrew Gibbs appears in our data through filings on Myriad Pharmaceuticals, Inc. shares, published by SEC (Form 4). In total, 3 filings cover trades dated from 1 July 2009 to 24 September 2010.
Every open-market trade on record is a sale: 1 sale worth €3,520. Other entries cover 2 share grants. Since January 2010: no purchases and 1 sale on the market.
The newest entry dates from 28 September 2010: a share grant, in Myriad Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Andrew Gibbs
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 12,000 shares0Common StockSEC:0001181431-10-048186:0
- 1,153 shares@ US$3.78Common StockSEC:0001181431-10-033915:0
- 9,000 shares0Common StockSEC:0001181431-09-034354:0
3 of 3 declarations
